Literature DB >> 556987

The diurnal urinary excretion of oxalate and the effect of pyridoxine and ascorbate on oxalate excretion.

H G Tiselius, L E Almgård.   

Abstract

The diurnal urinary oxalate excretion has been determined in 11 patients with urolithiasis and in 7 normal subjects. Increased excretion following meals was observed. The variation from hour to hour was most pronounced in the stone patient group. The relation between oxalate concentration and urinary volume was found to follow a biphasic exponential course. Pyridoxine administration increased oxalate excretion in 9 out of 12 subjects and decreased the excretion in 3 subjects. Ascorbate administration increased oxalate excretion in all 7 subjects studied.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 556987     DOI: 10.1159/000472053

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  9 in total

Review 1.  Advances in hereditary red cell enzyme anomalies.

Authors:  A Kahn; J C Kaplan; J C Dreyfus
Journal:  Hum Genet       Date:  1979       Impact factor: 4.132

Review 2.  Intestinal transport of an obdurate anion: oxalate.

Authors:  Marguerite Hatch; Robert W Freel
Journal:  Urol Res       Date:  2004-11-25

3.  Effects of oral pyridoxine upon plasma and 24-hour urinary oxalate levels in normal subjects and stone formers with idiopathic hypercalciuria.

Authors:  P Edwards; S Nemat; G A Rose
Journal:  Urol Res       Date:  1990

4.  Ascorbic acid and kidney stones.

Authors:  A Hoffer
Journal:  Can Med Assoc J       Date:  1985-02-15       Impact factor: 8.262

5.  Dietary treatment of nephrolithiasis.

Authors:  Antonio Nouvenne; Tiziana Meschi; Angela Guerra; Franca Allegri; Beatrice Prati; Loris Borghi
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

Review 6.  Vitamin therapy in the absence of obvious deficiency. What is the evidence?

Authors:  L Ovesen
Journal:  Drugs       Date:  1984-02       Impact factor: 9.546

7.  Control of hyperoxaluria with large doses of pyridoxine in patients with kidney stones.

Authors:  A Mitwalli; A Ayiomamitis; L Grass; D G Oreopoulos
Journal:  Int Urol Nephrol       Date:  1988       Impact factor: 2.370

8.  Vitamin B6 metabolites in idiopathic calcium stone formers: no evidence for a link to hyperoxaluria.

Authors:  Agnes Kaelin; Jean-Paul Casez; Philippe Jaeger
Journal:  Urol Res       Date:  2003-11-20

Review 9.  Calcium oxalate crystal deposition in the kidney: identification, causes and consequences.

Authors:  R Geraghty; K Wood; J A Sayer
Journal:  Urolithiasis       Date:  2020-07-27       Impact factor: 3.436

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.